Selected research
Industry Growth & Trends
Global Female Emergency Contraceptive Pill Industry Growth and Trends Forecast to 2032
Market perspective
The global Female Emergency Contraceptive Pill market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Female Emergency Contraceptive Pill is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Female Emergency Contraceptive Pill is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Female Emergency Contraceptive Pill is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Female Emergency Contraceptive Pill include Foundation Consumer Healthcare, Gedeon Richter, HLL Life Care, HRA Pharma, Lupin, Mankind Pharma, Piramal, Syzygy Healthcare and Regenex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Female Emergency Contraceptive Pill market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Female Emergency Contraceptive Pill market size, estimates, and forecasts are presented in terms of sales volume (K Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Female Emergency Contraceptive Pill market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Female Emergency Contraceptive Pill.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Female Emergency Contraceptive Pill market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Female Emergency Contraceptive Pill Market by Company
Foundation Consumer Healthcare
Gedeon Richter
HLL Life Care
HRA Pharma
Lupin
Mankind Pharma
Piramal
Syzygy Healthcare
Regenex
Zizhu Pharma
Sine Pharma
Zhejiang Xianju Pharma
Female Emergency Contraceptive Pill Segment by Type
Levonorgestrel
Ulipristal Acetate
Female Emergency Contraceptive Pill Segment by Application
Online
Offline
Female Emergency Contraceptive Pill Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Female Emergency Contraceptive Pill market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Female Emergency Contraceptive Pill and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Female Emergency Contraceptive Pill.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Female Emergency Contraceptive Pill manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Female Emergency Contraceptive Pill in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Levonorgestrel
- Ulipristal Acetate
Applications
- Online
- Offline
Companies covered
- Foundation Consumer Healthcare
- Gedeon Richter
- HLL Life Care
- HRA Pharma
- Lupin
- Mankind Pharma
- Piramal
- Syzygy Healthcare
- Regenex
- Zizhu Pharma
- Sine Pharma
- Zhejiang Xianju Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Female Emergency Contraceptive Pill Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Female Emergency Contraceptive Pill Sales Estimates and Forecasts (2021-2032)
- 1.3 Female Emergency Contraceptive Pill Market by Type
- 1.3.1 Levonorgestrel
- 1.3.2 Ulipristal Acetate
- 1.4 Global Female Emergency Contraceptive Pill Market Size by Type
- 1.4.1 Global Female Emergency Contraceptive Pill Market Size Overview by Type (2021-2032)
- 1.4.2 Global Female Emergency Contraceptive Pill Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Female Emergency Contraceptive Pill Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Female Emergency Contraceptive Pill Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Female Emergency Contraceptive Pill Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Female Emergency Contraceptive Pill Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Female Emergency Contraceptive Pill Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Female Emergency Contraceptive Pill Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Female Emergency Contraceptive Pill Industry Trends
- 2.2 Female Emergency Contraceptive Pill Industry Drivers
- 2.3 Female Emergency Contraceptive Pill Industry Opportunities and Challenges
- 2.4 Female Emergency Contraceptive Pill Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Female Emergency Contraceptive Pill Revenue (2021-2026)
- 3.2 Global Top Players by Female Emergency Contraceptive Pill Sales (2021-2026)
- 3.3 Global Top Players by Female Emergency Contraceptive Pill Price (2021-2026)
- 3.4 Global Female Emergency Contraceptive Pill Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Female Emergency Contraceptive Pill Major Company Production Sites & Headquarters
- 3.6 Global Female Emergency Contraceptive Pill Company, Product Type & Application
- 3.7 Global Female Emergency Contraceptive Pill Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Female Emergency Contraceptive Pill Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Female Emergency Contraceptive Pill Players Market Share by Revenue in 2025
- 3.8.3 2025 Female Emergency Contraceptive Pill Tier 1, Tier 2, and Tier 3
4 Female Emergency Contraceptive Pill Regional Status and Outlook
- 4.1 Global Female Emergency Contraceptive Pill Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Female Emergency Contraceptive Pill Historic Market Size by Region
- 4.2.1 Global Female Emergency Contraceptive Pill Sales in Volume by Region (2021-2026)
- 4.2.2 Global Female Emergency Contraceptive Pill Sales in Value by Region (2021-2026)
- 4.2.3 Global Female Emergency Contraceptive Pill Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Female Emergency Contraceptive Pill Forecasted Market Size by Region
- 4.3.1 Global Female Emergency Contraceptive Pill Sales in Volume by Region (2027-2032)
- 4.3.2 Global Female Emergency Contraceptive Pill Sales in Value by Region (2027-2032)
- 4.3.3 Global Female Emergency Contraceptive Pill Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Female Emergency Contraceptive Pill by Application
- 5.1 Female Emergency Contraceptive Pill Market by Application
- 5.1.1 Online
- 5.1.2 Offline
- 5.2 Global Female Emergency Contraceptive Pill Market Size by Application
- 5.2.1 Global Female Emergency Contraceptive Pill Market Size Overview by Application (2021-2032)
- 5.2.2 Global Female Emergency Contraceptive Pill Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Female Emergency Contraceptive Pill Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Female Emergency Contraceptive Pill Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Female Emergency Contraceptive Pill Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Female Emergency Contraceptive Pill Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Female Emergency Contraceptive Pill Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Female Emergency Contraceptive Pill Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Foundation Consumer Healthcare
- 6.1.1 Foundation Consumer Healthcare Company Information
- 6.1.2 Foundation Consumer Healthcare Business Overview
- 6.1.3 Foundation Consumer Healthcare Female Emergency Contraceptive Pill Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Foundation Consumer Healthcare Female Emergency Contraceptive Pill Product Portfolio
- 6.1.5 Foundation Consumer Healthcare Recent Developments
- 6.2 Gedeon Richter
- 6.2.1 Gedeon Richter Company Information
- 6.2.2 Gedeon Richter Business Overview
- 6.2.3 Gedeon Richter Female Emergency Contraceptive Pill Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Gedeon Richter Female Emergency Contraceptive Pill Product Portfolio
- 6.2.5 Gedeon Richter Recent Developments
- 6.3 HLL Life Care
- 6.3.1 HLL Life Care Company Information
- 6.3.2 HLL Life Care Business Overview
- 6.3.3 HLL Life Care Female Emergency Contraceptive Pill Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 HLL Life Care Female Emergency Contraceptive Pill Product Portfolio
- 6.3.5 HLL Life Care Recent Developments
- 6.4 HRA Pharma
- 6.4.1 HRA Pharma Company Information
- 6.4.2 HRA Pharma Business Overview
- 6.4.3 HRA Pharma Female Emergency Contraceptive Pill Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 HRA Pharma Female Emergency Contraceptive Pill Product Portfolio
- 6.4.5 HRA Pharma Recent Developments
- 6.5 Lupin
- 6.5.1 Lupin Company Information
- 6.5.2 Lupin Business Overview
- 6.5.3 Lupin Female Emergency Contraceptive Pill Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Lupin Female Emergency Contraceptive Pill Product Portfolio
- 6.5.5 Lupin Recent Developments
- 6.6 Mankind Pharma
- 6.6.1 Mankind Pharma Company Information
- 6.6.2 Mankind Pharma Business Overview
- 6.6.3 Mankind Pharma Female Emergency Contraceptive Pill Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Mankind Pharma Female Emergency Contraceptive Pill Product Portfolio
- 6.6.5 Mankind Pharma Recent Developments
- 6.7 Piramal
- 6.7.1 Piramal Company Information
- 6.7.2 Piramal Business Overview
- 6.7.3 Piramal Female Emergency Contraceptive Pill Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Piramal Female Emergency Contraceptive Pill Product Portfolio
- 6.7.5 Piramal Recent Developments
- 6.8 Syzygy Healthcare
- 6.8.1 Syzygy Healthcare Company Information
- 6.8.2 Syzygy Healthcare Business Overview
- 6.8.3 Syzygy Healthcare Female Emergency Contraceptive Pill Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Syzygy Healthcare Female Emergency Contraceptive Pill Product Portfolio
- 6.8.5 Syzygy Healthcare Recent Developments
- 6.9 Regenex
- 6.9.1 Regenex Company Information
- 6.9.2 Regenex Business Overview
- 6.9.3 Regenex Female Emergency Contraceptive Pill Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Regenex Female Emergency Contraceptive Pill Product Portfolio
- 6.9.5 Regenex Recent Developments
- 6.10 Zizhu Pharma
- 6.10.1 Zizhu Pharma Company Information
- 6.10.2 Zizhu Pharma Business Overview
- 6.10.3 Zizhu Pharma Female Emergency Contraceptive Pill Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Zizhu Pharma Female Emergency Contraceptive Pill Product Portfolio
- 6.10.5 Zizhu Pharma Recent Developments
- 6.11 Sine Pharma
- 6.11.1 Sine Pharma Company Information
- 6.11.2 Sine Pharma Business Overview
- 6.11.3 Sine Pharma Female Emergency Contraceptive Pill Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Sine Pharma Female Emergency Contraceptive Pill Product Portfolio
- 6.11.5 Sine Pharma Recent Developments
- 6.12 Zhejiang Xianju Pharma
- 6.12.1 Zhejiang Xianju Pharma Company Information
- 6.12.2 Zhejiang Xianju Pharma Business Overview
- 6.12.3 Zhejiang Xianju Pharma Female Emergency Contraceptive Pill Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Zhejiang Xianju Pharma Female Emergency Contraceptive Pill Product Portfolio
- 6.12.5 Zhejiang Xianju Pharma Recent Developments
7 North America by Country
- 7.1 North America Female Emergency Contraceptive Pill Sales by Country
- 7.1.1 North America Female Emergency Contraceptive Pill Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Female Emergency Contraceptive Pill Sales by Country (2021-2026)
- 7.1.3 North America Female Emergency Contraceptive Pill Sales Forecast by Country (2027-2032)
- 7.2 North America Female Emergency Contraceptive Pill Market Size by Country
- 7.2.1 North America Female Emergency Contraceptive Pill Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Female Emergency Contraceptive Pill Market Size by Country (2021-2026)
- 7.2.3 North America Female Emergency Contraceptive Pill Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Female Emergency Contraceptive Pill Sales by Country
- 8.1.1 Europe Female Emergency Contraceptive Pill Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Female Emergency Contraceptive Pill Sales by Country (2021-2026)
- 8.1.3 Europe Female Emergency Contraceptive Pill Sales Forecast by Country (2027-2032)
- 8.2 Europe Female Emergency Contraceptive Pill Market Size by Country
- 8.2.1 Europe Female Emergency Contraceptive Pill Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Female Emergency Contraceptive Pill Market Size by Country (2021-2026)
- 8.2.3 Europe Female Emergency Contraceptive Pill Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Female Emergency Contraceptive Pill Sales by Country
- 9.1.1 Asia-Pacific Female Emergency Contraceptive Pill Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Female Emergency Contraceptive Pill Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Female Emergency Contraceptive Pill Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Female Emergency Contraceptive Pill Market Size by Country
- 9.2.1 Asia-Pacific Female Emergency Contraceptive Pill Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Female Emergency Contraceptive Pill Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Female Emergency Contraceptive Pill Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Female Emergency Contraceptive Pill Sales by Country
- 10.1.1 South America Female Emergency Contraceptive Pill Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Female Emergency Contraceptive Pill Sales by Country (2021-2026)
- 10.1.3 South America Female Emergency Contraceptive Pill Sales Forecast by Country (2027-2032)
- 10.2 South America Female Emergency Contraceptive Pill Market Size by Country
- 10.2.1 South America Female Emergency Contraceptive Pill Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Female Emergency Contraceptive Pill Market Size by Country (2021-2026)
- 10.2.3 South America Female Emergency Contraceptive Pill Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Female Emergency Contraceptive Pill Sales by Country
- 11.1.1 Middle East and Africa Female Emergency Contraceptive Pill Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Female Emergency Contraceptive Pill Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Female Emergency Contraceptive Pill Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Female Emergency Contraceptive Pill Market Size by Country
- 11.2.1 Middle East and Africa Female Emergency Contraceptive Pill Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Female Emergency Contraceptive Pill Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Female Emergency Contraceptive Pill Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Female Emergency Contraceptive Pill Value Chain Analysis
- 12.1.1 Female Emergency Contraceptive Pill Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Female Emergency Contraceptive Pill Production Mode & Process
- 12.2 Female Emergency Contraceptive Pill Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Female Emergency Contraceptive Pill Distributors
- 12.2.3 Female Emergency Contraceptive Pill Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst